Braun Stacey Associates Inc. Grows Stock Position in Celsius Holdings Inc. $CELH

Braun Stacey Associates Inc. increased its stake in shares of Celsius Holdings Inc. (NASDAQ:CELH) by 15.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 595,901 shares of the company’s stock after purchasing an additional 78,027 shares during the quarter. Celsius accounts for approximately 1.1% of Braun Stacey Associates Inc.’s holdings, making the stock its 22nd biggest position. Braun Stacey Associates Inc. owned approximately 0.23% of Celsius worth $34,258,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Alliancebernstein L.P. raised its position in Celsius by 3.4% during the 2nd quarter. Alliancebernstein L.P. now owns 18,662,921 shares of the company’s stock worth $865,773,000 after buying an additional 617,743 shares during the last quarter. Ameriprise Financial Inc. increased its stake in shares of Celsius by 20.9% during the second quarter. Ameriprise Financial Inc. now owns 2,470,088 shares of the company’s stock worth $114,587,000 after acquiring an additional 426,623 shares during the period. Holocene Advisors LP raised its holdings in Celsius by 130.6% during the second quarter. Holocene Advisors LP now owns 2,108,041 shares of the company’s stock worth $97,792,000 after purchasing an additional 1,193,707 shares in the last quarter. Divisadero Street Capital Management LP lifted its position in Celsius by 89.4% in the second quarter. Divisadero Street Capital Management LP now owns 1,497,450 shares of the company’s stock valued at $69,467,000 after purchasing an additional 706,888 shares during the period. Finally, Mane Global Capital Management LP lifted its position in Celsius by 121.3% in the second quarter. Mane Global Capital Management LP now owns 1,486,418 shares of the company’s stock valued at $68,955,000 after purchasing an additional 814,890 shares during the period. 60.95% of the stock is owned by institutional investors and hedge funds.

Celsius Stock Down 0.9%

Celsius stock opened at $45.74 on Friday. Celsius Holdings Inc. has a fifty-two week low of $21.10 and a fifty-two week high of $66.74. The firm has a market capitalization of $11.79 billion, a price-to-earnings ratio of 457.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.89. The stock’s fifty day moving average is $46.12 and its two-hundred day moving average is $50.71. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.61 and a current ratio of 1.89.

Celsius (NASDAQ:CELH) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.14. Celsius had a return on equity of 41.88% and a net margin of 3.03%.The business had revenue of $725.11 million during the quarter, compared to the consensus estimate of $703.68 million. The business’s revenue for the quarter was up 172.9% compared to the same quarter last year. Analysts predict that Celsius Holdings Inc. will post 0.89 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CELH. Stifel Nicolaus cut their target price on Celsius from $74.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Citigroup dropped their price objective on Celsius from $73.00 to $65.00 and set a “buy” rating on the stock in a report on Friday, November 7th. KeyCorp began coverage on Celsius in a report on Tuesday, December 16th. They issued a “sector weight” rating for the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Celsius in a research note on Monday. Finally, UBS Group reiterated a “buy” rating on shares of Celsius in a report on Wednesday, December 17th. Twenty equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $63.89.

Insiders Place Their Bets

In other Celsius news, Director Hal Kravitz bought 10,000 shares of the business’s stock in a transaction on Thursday, November 13th. The stock was bought at an average price of $45.24 per share, for a total transaction of $452,400.00. Following the completion of the transaction, the director owned 216,147 shares in the company, valued at approximately $9,778,490.28. The trade was a 4.85% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jarrod Langhans sold 5,000 shares of the company’s stock in a transaction dated Thursday, October 16th. The shares were sold at an average price of $65.00, for a total transaction of $325,000.00. Following the completion of the sale, the chief financial officer directly owned 99,227 shares in the company, valued at $6,449,755. This trade represents a 4.80% decrease in their position. The SEC filing for this sale provides additional information. 2.55% of the stock is currently owned by company insiders.

Celsius Company Profile

Celsius Holdings, Inc is an American beverage company known for its line of fitness and energy drinks formulated to support active lifestyles. The company’s flagship product, the Celsius® brand, features beverages enhanced with ingredients such as green tea extract, guarana seed extract and essential vitamins, positioned as a functional alternative to traditional energy drinks. These products are designed to deliver a blend of ingredients that support metabolism and sustained energy without high sugar content or artificial preservatives.

In addition to its core carbonated drink portfolio, Celsius has expanded its offerings to include powder mixes and non-carbonated ready-to-drink variants, catering to consumer preferences around taste, convenience and nutritional needs.